Aurobindo Pharma informs about press release

21 Dec 2024 Evaluate
Aurobindo Pharma has informed that it enclosed copy of the Press Release that is being issued by the Company announcing that CuraTeQ Biologics s.r.o., a step-down subsidiary of the Company has obtained marketing authorisation from UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Bevqolva, its bevacizumab biosimilar version.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1300.30 29.90 (2.35%)
30-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1882.20
Dr. Reddys Lab 1377.55
Cipla 1520.65
Lupin 2309.65
Zydus Lifesciences 957.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.